Showing results (381-390 of 757) with videos related to
Sort By:
Pageof 76
Transplantation|February 13, 2015
Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation StudyChristiane Drechsler, Hege Pihlstrøm, Andreas Meinitzer, et al.Advances in Therapy|December 2, 2024
Addressing the Human Experience of Chronic Kidney Disease: A Call to Transform Kidney CareRicardo Correa-Rotter, Steven J Chadban, Laura Christen, et al.Journal of the American Society of Nephrology : JASN|May 23, 2003
Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoAJan Galle, Alexander Mameghani, Steffen-Sebastian Bolz, et al.BMC Nephrology|October 27, 2017
Patient's and physician's awareness of kidney disease in coronary heart disease patients - a cross-sectional analysis of the German subset of the EUROASPIRE IV surveyMartin Wagner, Christoph Wanner, Martin Schich, et al.Orphanet Journal of Rare Diseases|July 7, 2026
Automated quantification of skin Gb3 load and white matter lesion assessment in Fabry diseaseCatharina Pfister, Magnus Schindehütte, Christoph Erbacher, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 16, 2024
A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial HypertensionPantelis Sarafidis, Roland Schmieder, Michel Burnier, et al.Journal of Hypertension|April 19, 2005
Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loadingThomas Quaschning, Benjamin Rebhan, Christoph Wunderlich, et al.ESC Heart Failure|December 29, 2023
Kidney and heart failure events are bidirectionally associated in patients with type 2 diabetes and cardiovascular diseaseAbhinav Sharma, Silvio E Inzucchi, Jeffrey M Testani, et al.Stroke|July 14, 2023
Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome TrialsPriyadarshini Balasubramanian, Walter N Kernan, Kevin N Sheth, et al.American Journal of Preventive Cardiology|June 29, 2023
Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome: Analysis of EMPA-REG OUTCOME using REDUCE-IT criteriaSubodh Verma, Andrew Kosmopoulos, Deepak L Bhatt, et al.Pageof 76